Eberhard Steiner

1.6k total citations
50 papers, 1.1k citations indexed

About

Eberhard Steiner is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Eberhard Steiner has authored 50 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in Eberhard Steiner's work include Prostate Cancer Treatment and Research (16 papers), Prostate Cancer Diagnosis and Treatment (13 papers) and Alzheimer's disease research and treatments (7 papers). Eberhard Steiner is often cited by papers focused on Prostate Cancer Treatment and Research (16 papers), Prostate Cancer Diagnosis and Treatment (13 papers) and Alzheimer's disease research and treatments (7 papers). Eberhard Steiner collaborates with scholars based in Austria, Germany and Italy. Eberhard Steiner's co-authors include Imrich Blasko, B. Grubeck‐Loebenstein, Florentine Marx, Tobias Hartmann, Helmut Klocker, Wolfgang Horninger, Georg Schäfer, Georg Bartsch, Friedrich Aigner and Thomas Schmitt and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and The FASEB Journal.

In The Last Decade

Eberhard Steiner

45 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eberhard Steiner Austria 18 375 345 261 164 156 50 1.1k
Jason S. Ogiste United States 7 615 1.6× 80 0.2× 498 1.9× 96 0.6× 38 0.2× 9 1.4k
Angela Wirth Germany 15 856 2.3× 104 0.3× 327 1.3× 38 0.2× 25 0.2× 26 1.4k
Xu Gao China 22 916 2.4× 464 1.3× 61 0.2× 21 0.1× 155 1.0× 66 1.7k
Takashi Ota Japan 16 478 1.3× 42 0.1× 218 0.8× 124 0.8× 20 0.1× 37 1.2k
Gina M. Warner United States 23 576 1.5× 148 0.4× 339 1.3× 72 0.4× 4 0.0× 29 1.8k
Yasushi Ito Japan 18 365 1.0× 67 0.2× 346 1.3× 119 0.7× 5 0.0× 51 1.1k
Reena Rao United States 19 906 2.4× 220 0.6× 168 0.6× 14 0.1× 20 0.1× 26 1.4k
Nan Mu China 24 774 2.1× 115 0.3× 216 0.8× 52 0.3× 4 0.0× 55 1.5k
Yuka Kaneko Japan 17 363 1.0× 145 0.4× 208 0.8× 55 0.3× 7 0.0× 82 1.2k

Countries citing papers authored by Eberhard Steiner

Since Specialization
Citations

This map shows the geographic impact of Eberhard Steiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eberhard Steiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eberhard Steiner more than expected).

Fields of papers citing papers by Eberhard Steiner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eberhard Steiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eberhard Steiner. The network helps show where Eberhard Steiner may publish in the future.

Co-authorship network of co-authors of Eberhard Steiner

This figure shows the co-authorship network connecting the top 25 collaborators of Eberhard Steiner. A scholar is included among the top collaborators of Eberhard Steiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eberhard Steiner. Eberhard Steiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Helmold, Marc, et al.. (2023). New Work, Neues Arbeiten virtuell und in Präsenz. 1 indexed citations
2.
Frantzi, Maria, Isabel Heidegger, Enrique Gómez‐Gómez, et al.. (2022). Validation of diagnostic nomograms based on CE–MS urinary biomarkers to detect clinically significant prostate cancer. World Journal of Urology. 40(9). 2195–2203. 8 indexed citations
3.
Klocker, Helmut, Bruno Golding, Stephan Weber, et al.. (2020). Development and validation of a novel multivariate risk score to guide biopsy decision for the diagnosis of clinically significant prostate cancer. BJUI Compass. 1(1). 15–20. 28 indexed citations
4.
Pircher, Andreas, Georg Schäfer, Andrea Eigentler, et al.. (2019). Robo 4 - the double-edged sword in prostate cancer: impact on cancer cell aggressiveness and tumor vasculature. International Journal of Medical Sciences. 16(1). 115–124. 3 indexed citations
5.
Heidegger, Isabel, Eberhard Steiner, Helmut Klocker, et al.. (2015). High Risk of Under-Grading and -Staging in Prostate Cancer Patients Eligible for Active Surveillance. PLoS ONE. 10(2). e0115537–e0115537. 20 indexed citations
6.
Oswald, Josef, Isabel Heidegger, Eberhard Steiner, et al.. (2013). Gender-related Fetal Development of the Internal Urethral Sphincter. Urology. 82(6). 1410–1415. 7 indexed citations
7.
Schaefer, Georg, Reinhold Ramoner, Alessandro Romanel, et al.. (2013). Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer. Prostate Cancer and Prostatic Diseases. 16(2). 132–138. 50 indexed citations
8.
Kuner, Ruprecht, Maria Fälth, Jan C. Brase, et al.. (2012). The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer. Journal of Molecular Medicine. 91(2). 237–248. 119 indexed citations
9.
Setlur, Sunita R., Chen X. Chen, Jung‐Sook Ha, et al.. (2010). Genetic Variation of Genes Involved in Dihydrotestosterone Metabolism and the Risk of Prostate Cancer. Cancer Epidemiology Biomarkers & Prevention. 19(1). 229–239. 47 indexed citations
10.
Mitterberger, Michael, Friedrich Aigner, Germar‐Michael Pinggera, et al.. (2010). Contrast‐enhanced colour Doppler‐targeted prostate biopsy: correlation of a subjective blood‐flow rating scale with the histopathological outcome of the biopsy. British Journal of Urology. 106(9). 1315–1318. 17 indexed citations
11.
Mitterberger, Michael, Wolfgang Horninger, Friedrich Aigner, et al.. (2009). Contrast‐enhanced colour Doppler‐targeted vs a 10‐core systematic repeat biopsy strategy in patients with previous high‐grade prostatic intraepithelial neoplasia. British Journal of Urology. 105(12). 1660–1662. 8 indexed citations
12.
13.
Klocker, Helmut, Georg Schäfer, Van-Duc Luu, et al.. (2009). Differential expression of apoptotic genes PDIA3 and MAP3K5 distinguishes between low- and high-risk prostate cancer. Molecular Cancer. 8(1). 130–130. 62 indexed citations
14.
Colleselli, Daniela, Alexandré Pelzer, Eberhard Steiner, et al.. (2009). Upgrading of Gleason score 6 prostate cancers on biopsy after prostatectomy in the low and intermediate tPSA range. Prostate Cancer and Prostatic Diseases. 13(2). 182–185. 21 indexed citations
15.
Pelzer, Alexandré, Daniela Colleselli, Jasmin Bektić, et al.. (2008). Pathological features of Gleason score 6 prostate cancers in the low and intermediate range of prostate‐specific antigen level: is there a difference?. British Journal of Urology. 101(7). 822–825. 8 indexed citations
16.
Pelzer, Alexandré, Daniela Colleselli, Jasmin Bektić, et al.. (2008). Over‐diagnosis and under‐diagnosis of screen‐ vs non‐screen‐detected prostate cancers with in men with prostate‐specific antigen levels of 2.0–10.0 ng/mL. British Journal of Urology. 101(10). 1223–1226. 6 indexed citations
17.
Pinggera, Germar‐Michael, Michael Mitterberger, Eberhard Steiner, et al.. (2008). Association of lower urinary tract symptoms and chronic ischaemia of the lower urinary tract in elderly women and men: assessment using colour Doppler ultrasonography. British Journal of Urology. 102(4). 470–474. 121 indexed citations
18.
Schwingshackl, Andreas, Imrich Blasko, Eberhard Steiner, et al.. (1998). Sex Steroids Do Not Prevent Amylin-Induced Apoptosis in Human Cells. Experimental Cell Research. 241(1). 265–268. 6 indexed citations
19.
Blasko, Imrich, Thomas Schmitt, Eberhard Steiner, Klemens Trieb, & Beatrix Grubeck‐Loebenstein. (1997). Tumor necrosis factor α augments amyloid β protein (25–35) induced apoptosis in human cells. Neuroscience Letters. 238(1-2). 17–20. 41 indexed citations
20.
Sztankay, A., et al.. (1994). Interferon Gamma and Iodide Increase the Inducibility of the 72 kD Heat Shock Protein in Cultured Human Thyroid Epithelial Cells. Journal of Autoimmunity. 7(2). 219–230. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jason S. Ogiste Breakdown of academic impact, for papers by Angela Wirth Breakdown of academic impact, for papers by Xu Gao Breakdown of academic impact, for papers by Takashi Ota Breakdown of academic impact, for papers by Gina M. Warner Breakdown of academic impact, for papers by Yasushi Ito Breakdown of academic impact, for papers by Reena Rao Breakdown of academic impact, for papers by Nan Mu Breakdown of academic impact, for papers by Yuka Kaneko
Rankless by CCL
2026